This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN inched 0.44% higher to $2.26 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.27% to 31,029.31 and the S&P 500 Index SPX falling 0.07% to 3,818.83. The stock's rise snapped a three-day losing streak. Ocugen Inc. closed $15.39 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM rose 0.85% to $1.18, Ocular Therapeutix Inc. OCUL rose 2.64% to $3.89, and Kodiak Sciences Inc. KOD fell 1.25% to $7.92. Trading volume (4.2 M) remained 3.0 million below its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 29, 2022.
(END) Dow Jones Newswires
June 29, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.